Brief: Polyrizon Commences Gmp Manufacturing Preliminary Process
23/01/2025 11:55
Jan 23 (Reuters) - Polyrizon Ltd PLRZ.O :
* POLYRIZON COMMENCES GMP MANUFACTURING PRELIMINARY PROCESS
FOR
ITS PL-14 ALLERGY BLOCKER IN PREPARATION FOR PLANNED 2025
CLINICAL TRIAL
Source text: ID:nGNX2snD0g
Further company coverage: PLRZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Polyrizon
See all newsBrief: Polyrizon Files For U.S. Patent Application To Expand Ip Moat Around Intranasal Drug-Delivery Platform
Brief: Polyrizon Advances Towards Human Clinical Trials Secures First U.S. Clinical Site For Nasarix™ Allergy Blocker Clinical Trial
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:58 AM
Enters Agreements For Registered Direct Offering Of Ordinary Shares And Pre-Funded Warrants
U.S. STOCKS ON THE MOVE-Enovis, Cheniere, Packaging Corp of America